"Our findings suggest that, in the condition of negative sentinel lymph nodes, omitting pelvic lymphadenectomy does not ...

Jacob E. Berchuck, MD, highlights challenges in adopting liquid biopsy for PSMA expression and its potential to revolutionize precision medicine in prostate cancer.

The advent of effective antiretroviral therapy (ART) has increased the lifespan of many people living with HIV. As a result, ...

Scientists are developing a less invasive portable device that would use blood samples to detect colorectal cancers.

and identified trends in cervical intraepithelial neoplasia 2+ (CIN2+; defined as CIN grades 2-3 and adenocarcinoma in situ) and CIN3+ (defined as CIN grade 3 and adenocarcinoma in situ).

SUV remains the most widely used PET parameter to evaluate NHLs because it is directly associated with lymphoma aggressiveness.

The firm is preparing for a trial to show the efficacy of its CyPath Lung test and support a submission to the US Food and Drug Administration for marketing clearance.

There is currently no schedule data. The Schedule Release will be available on April.